HCG Manavata Cancer Centre
HIFU for prostate cancer treatment in India typically costs from AUD $8,090 to AUD $12,414. Final prices depend on whether the patient requires focal or whole-gland ablation and the hospital category. In Australia, similar procedures cost around AUD $22,179 on average. Patients save approximately 53% by travelling to India. Treatment often includes the procedure, hospital stays, and initial diagnostic imaging.
Bookimed Expert Insight: India offers exceptional value through highly experienced surgeons at centres like HCG Manavata Cancer Centre. Specialist surgeons here, such as Dr. Raj Nagarkar, have performed over 50,000 surgeries. This high level of expertise is often available at a fraction of Australian private costs. Choosing an NABH-accredited facility ensures the clinic meets strict national quality and safety standards.
| India | Thailand | Turkey | |
| HIFU for prostate cancer treatment | from AUD $8,090 | from AUD $13,949 | from AUD $9,764 |
No hidden fees – just official clinic prices. Pay at the clinic for HIFU for prostate cancer treatment upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in HIFU for prostate cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your HIFU for prostate cancer treatment journey.
Dr Sridhar P.S. is a specialist in precision radiation oncology and focal therapy at the HCG Manavata Cancer Centre. He holds a Diplomate of the National Board in radiotherapy and manages complex prostate cases.
The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.
Dr. Shruti Kate is a medical oncologist at HCG Manavata Cancer Centre in Nashik. She previously worked as a consultant at the Tata Memorial Hospital in Mumbai. Dr. Kate focuses on immunotherapy and metronomic therapy for treating solid and pediatric tumors. She was the sole recipient from India of the 2018 World Conference on Lung Cancer award.
Dr. Lalit Banswal is a surgical oncologist at HCG Manavata Cancer Centre in Nashik. He has successfully performed more than 10,000 major surgeries. Dr. Banswal focuses on gastrointestinal cancer and robotic surgical techniques. He completed a two-year fellowship at the Tata Medical Centre, Kolkata.